Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162572
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-11-29
Brief Title:
Phase 1b2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer NSCLC
Sponsor:
Servier Bio-Innovation LLC
Organization:
Servier
Organization Data
Organization:
Servier
Class:
INDUSTRY
Study ID:
SPLFIO-174
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Servier Bio-Innovation LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Institut de Recherches Internationales Servier | OTHER |
| Regeneron Pharmaceuticals | INDUSTRY |